{"id":66346,"date":"2026-05-26T15:08:33","date_gmt":"2026-05-26T07:08:33","guid":{"rendered":"https:\/\/flcube.com\/?p=66346"},"modified":"2026-05-26T15:08:34","modified_gmt":"2026-05-26T07:08:34","slug":"peak-pharmaceutical-partners-with-shanghai-pharma-subsidiary-to-optimize-neffy-supply-chain-and-channel-development-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=66346","title":{"rendered":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Peak Pharmaceutical Co., Ltd.<\/strong> announced a <strong>strategic partnership<\/strong> with <strong>SPH Kyuan Trade<\/strong>, a core subsidiary of <strong>Shanghai Pharmaceuticals Holding Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/601607:SHA\">SHA: 601607<\/a>), to jointly drive <strong>supply chain optimization<\/strong> and <strong>channel development<\/strong> for <strong>Neffy (epinephrine nasal spray)<\/strong>, a <strong>critical emergency treatment for severe allergic reactions<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-partnership-structure-amp-strategic-framework\" class=\"wp-block-heading\">Partnership Structure &amp; Strategic Framework<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Partnership Element<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Peak Pharmaceutical (innovation partner) \/ SPH Kyuan Trade (commercial partner)<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>Neffy (epinephrine nasal spray) \u2013 emergency treatment for anaphylaxis<\/td><\/tr><tr><td><strong>Collaboration Model<\/strong><\/td><td>&#8220;Deeply collaborative model&#8221; for supply chain and channel optimization<\/td><\/tr><tr><td><strong>Strategic Vision<\/strong><\/td><td>Create replicable pathway for future innovative drug rollouts in China<\/td><\/tr><tr><td><strong>Operating Philosophy<\/strong><\/td><td>&#8220;<strong>Global innovation introduction + local deep operation<\/strong>&#8220;<\/td><\/tr><tr><td><strong>Therapeutic Focus<\/strong><\/td><td>Unmet medical needs in <strong>internal medicine and pediatrics<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership leverages Peak Pharmaceutical&#8217;s global innovation access capabilities with SPH Kyuan Trade&#8217;s established commercial infrastructure and distribution network across China.<\/p>\n\n\n\n<h2 id=\"h-asset-profile-amp-market-opportunity\" class=\"wp-block-heading\">Asset Profile &amp; Market Opportunity<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Product:<\/strong> <strong>Neffy (epinephrine nasal spray)<\/strong> \u2013 first-in-class nasal epinephrine formulation<\/li>\n\n\n\n<li><strong>Indication:<\/strong> <strong>Emergency treatment of severe allergic reactions (anaphylaxis)<\/strong><\/li>\n\n\n\n<li><strong>Market Need:<\/strong> Addresses critical gap in emergency allergy treatment accessibility in China<\/li>\n\n\n\n<li><strong>Competitive Advantage:<\/strong> Non-injectable administration preferred by patients, caregivers, and schools<\/li>\n\n\n\n<li><strong>Regulatory Status:<\/strong> Assumed approved or nearing approval in China (partnership implies market readiness)<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-capabilities-amp-resource-integration\" class=\"wp-block-heading\">Strategic Capabilities &amp; Resource Integration<\/h2>\n\n\n\n<h3 id=\"h-peak-pharmaceutical-advantages\" class=\"wp-block-heading\">Peak Pharmaceutical Advantages<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global Sourcing Network:<\/strong> Leverages <strong>CBC Group shareholder investment network<\/strong> for rapid access to overseas assets<\/li>\n\n\n\n<li><strong>Asset Selection:<\/strong> Focus on <strong>first-in-class and clinically urgent drug assets<\/strong><\/li>\n\n\n\n<li><strong>Therapeutic Expertise:<\/strong> Specialized focus on internal medicine and pediatrics unmet needs<\/li>\n\n\n\n<li><strong>Innovation Pipeline:<\/strong> Establishing model for future innovative drug introductions<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-sph-kyuan-trade-shanghai-pharma-advantages\" class=\"wp-block-heading\">SPH Kyuan Trade\/ Shanghai Pharma Advantages<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Distribution Infrastructure:<\/strong> Extensive nationwide hospital and retail pharmacy network<\/li>\n\n\n\n<li><strong>Supply Chain Expertise:<\/strong> Cold chain and specialty pharmaceutical logistics capabilities<\/li>\n\n\n\n<li><strong>Commercial Scale:<\/strong> Access to China&#8217;s largest pharmaceutical distribution platform<\/li>\n\n\n\n<li><strong>Regulatory Experience:<\/strong> Proven track record in navigating Chinese regulatory landscape<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-commercial-outlook\" class=\"wp-block-heading\">Market Impact &amp; Commercial Outlook<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Market Element<\/th><th>Assessment<\/th><\/tr><\/thead><tbody><tr><td><strong>Anaphylaxis Treatment Market<\/strong><\/td><td>Estimated 50-100 million at-risk individuals in China; growing awareness and diagnosis rates<\/td><\/tr><tr><td><strong>Current Standard of Care<\/strong><\/td><td>Epinephrine auto-injectors (EpiPen equivalents) \u2013 injection anxiety limits adoption<\/td><\/tr><tr><td><strong>Neffy Differentiation<\/strong><\/td><td>Nasal spray format addresses patient preference and ease-of-use barriers<\/td><\/tr><tr><td><strong>Commercial Timeline<\/strong><\/td><td>Rapid market entry expected given established partnership infrastructure<\/td><\/tr><tr><td><strong>Revenue Potential<\/strong><\/td><td>Premium pricing justified by emergency use indication and novel delivery format<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership represents a new model for innovative drug commercialization in China, combining global asset identification with local operational excellence.<\/p>\n\n\n\n<h2 id=\"h-broader-industry-implications\" class=\"wp-block-heading\">Broader Industry Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Replicable Model:<\/strong> Success could establish template for future innovative drug partnerships<\/li>\n\n\n\n<li><strong>Market Access Acceleration:<\/strong> Reduces time-to-market for globally developed therapeutics<\/li>\n\n\n\n<li><strong>Investment Attraction:<\/strong> Demonstrates viable pathway for international biotech companies seeking China market entry<\/li>\n\n\n\n<li><strong>Patient Access Improvement:<\/strong> Enhances availability of cutting-edge treatments for Chinese patients<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding partnership performance, market penetration, and commercial expectations for Neffy. Actual results may differ due to risks including regulatory approvals, market adoption, competitive dynamics, and execution challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary&#8230;<\/p>\n","protected":false},"author":1,"featured_media":66347,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[3944,891,196],"class_list":["post-66346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-peak-pharmaceutical","tag-sha-601607","tag-shanghai-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=66346\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China\" \/>\n<meta property=\"og:description\" content=\"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=66346\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T07:08:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-26T07:08:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China\",\"datePublished\":\"2026-05-26T07:08:33+00:00\",\"dateModified\":\"2026-05-26T07:08:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346\"},\"wordCount\":481,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2601-1.webp\",\"keywords\":[\"Peak Pharmaceutical\",\"SHA: 601607\",\"Shanghai Pharmaceuticals\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66346#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=66346\",\"name\":\"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2601-1.webp\",\"datePublished\":\"2026-05-26T07:08:33+00:00\",\"dateModified\":\"2026-05-26T07:08:34+00:00\",\"description\":\"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=66346\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2601-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/2601-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=66346#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China - Insight, China&#039;s Pharmaceutical Industry","description":"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=66346","og_locale":"en_US","og_type":"article","og_title":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China","og_description":"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.","og_url":"https:\/\/flcube.com\/?p=66346","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-26T07:08:33+00:00","article_modified_time":"2026-05-26T07:08:34+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=66346#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=66346"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China","datePublished":"2026-05-26T07:08:33+00:00","dateModified":"2026-05-26T07:08:34+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=66346"},"wordCount":481,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=66346#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","keywords":["Peak Pharmaceutical","SHA: 601607","Shanghai Pharmaceuticals"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=66346#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=66346","url":"https:\/\/flcube.com\/?p=66346","name":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=66346#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=66346#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","datePublished":"2026-05-26T07:08:33+00:00","dateModified":"2026-05-26T07:08:34+00:00","description":"Peak Pharmaceutical Co., Ltd. announced a strategic partnership with SPH Kyuan Trade, a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SHA: 601607), to jointly drive supply chain optimization and channel development for Neffy (epinephrine nasal spray), a critical emergency treatment for severe allergic reactions.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=66346#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=66346"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=66346#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","width":1080,"height":608,"caption":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=66346#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Peak Pharmaceutical Partners with Shanghai Pharma Subsidiary to Optimize Neffy Supply Chain and Channel Development in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2601-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=66346"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66346\/revisions"}],"predecessor-version":[{"id":66348,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/66346\/revisions\/66348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/66347"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=66346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=66346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=66346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}